Andrew Bulpin
Head of Process Solutions
surgery
Merck Millipore,
New Zealand
Biography
Andrew Bulpin is Head of the Process Solutions Business Unit within Life Science. In this role, he oversees Research & Development, Product Management and Marketing, and the Services organization, as well as the Process Solutions Commercial teams. Most recently, Bulpin was Head of the Process Solutions Strategic Marketing & Innovation (SMI) team for Life Science. Prior to that, Bulpin served as Executive Vice President of Process Solutions for Merck. Bulpin joined Millipore in 2006 as Vice President for the Upstream Processing business and later assumed leadership of the Services and Solutions business. Following the company's acquisition by Merck in 2010, he served as Global Head of Sales for the Pharmaceutical Chemical Solutions business. Prior to joining Millipore, Andrew worked at Serologicals Corporation in a number of sales and marketing roles, both in the U.S. and Europe. Andrew holds a Ph.D. in Organic Chemistry from the Université de Caen, France, a Master of Business Administration degree from the University of Strathclyde, Scotland, and a Bachelor degree from the University of Sussex, England. He also worked as a Post-Doctoral Research Fellow at the Australian National University, Australia.
Research Interest
surgery